Literature DB >> 32129496

Cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 infections in patients with myalgic еncephalomyelitis/chronic fatigue syndrome.

Evelina Shikova1,2, Valentina Reshkova3, Аntoniya Kumanova1, Sevdalina Raleva1, Dora Alexandrova2, Natasa Capo4,5, Modra Murovska6.   

Abstract

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling multisystem chronic disease. The etiology and pathogenesis of ME/CFS are unknown. Infections of cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human herpesvirus-6 (HHV-6) are suspected as etiological agents for ME/CFS. This study aims to estimate prevalence and type (active/latent) of EBV, CMV, and HHV-6 infections in Bulgarian ME/CFS patients. In the study were included 58 patients with ME/CFS and 50 healthy controls. Virus-specific antibodies were detected by enzyme-linked immunosorbent assay and viral genomic sequences in peripheral blood mononuclear cell (PBMCs) and plasma samples by nested polymerase chain reaction (PCR). We did not observe any significant differences in virus-specific immunoglobulin G and immunoglobulin M positivity rates between patients with ME/CFS and control group. In ME/CFS plasma samples, EBV DNA was found in 24.1%, CMV DNA in 3.4%, and HHV-6 DNA in 1.7% of samples. EBV DNA was detected in 4%, and CMV and HHV-6 DNA were not found in plasma samples of controls. The frequency of viral genome detection in PBMCs of patients and controls was 74% vs 78% for CMV, 81% vs 84% for EBV, and 82.8% vs 82% for HHV-6. The difference in frequency of EBV active infection in ME/CFS and control group was statistically significant (P = .0027). No ME/CFS and control individuals with active CMV and HHV-6 infection were observed. In conclusion, this study using both serological and PCR-based techniques for distinguishing between active and latent infection showed high rate of active EBV infection among patients with ME/CFS indicating that at least in a subset of cases, EBV is important factor for the development of disease.
© 2020 The Authors. Journal of Medical Virology published by Wiley Periodicals, Inc.

Entities:  

Keywords:  CMV; EBV; ELISA; HHV-6 infection; PCR; active infection; myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Year:  2020        PMID: 32129496     DOI: 10.1002/jmv.25744

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  14 in total

1.  Patient perceptions of infectious illnesses preceding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Leonard A Jason; Samuel Yoo; Shaun Bhatia
Journal:  Chronic Illn       Date:  2021-09-20

2.  Revisiting IgG Antibody Reactivity to Epstein-Barr Virus in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Its Potential Application to Disease Diagnosis.

Authors:  Nuno Sepúlveda; João Malato; Franziska Sotzny; Anna D Grabowska; André Fonseca; Clara Cordeiro; Luís Graça; Przemyslaw Biecek; Uta Behrends; Josef Mautner; Francisco Westermeier; Eliana M Lacerda; Carmen Scheibenbogen
Journal:  Front Med (Lausanne)       Date:  2022-06-24

Review 3.  Animal Models for Neuroinflammation and Potential Treatment Methods.

Authors:  Yasuhisa Tamura; Masanori Yamato; Yosky Kataoka
Journal:  Front Neurol       Date:  2022-06-27       Impact factor: 4.086

4.  Human Herpesvirus 6 Infection and Risk of Chronic Fatigue Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Sayed-Hamidreza Mozhgani; Farid Rajabi; Mohsen Qurbani; Yousef Erfani; Somayeh Yaslianifard; Azam Moosavi; Kiomars Pourrostami; Ali Baradaran Bagheri; Alireza Soleimani; Farida Behzadian; Mahshid Safavi; Farhad Rezaei
Journal:  Intervirology       Date:  2021-06-23       Impact factor: 1.763

Review 5.  Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology.

Authors:  Fernando Estévez-López; Kathleen Mudie; Xia Wang-Steverding; Inger Johanne Bakken; Andrejs Ivanovs; Jesús Castro-Marrero; Luis Nacul; Jose Alegre; Paweł Zalewski; Joanna Słomko; Elin Bolle Strand; Derek Pheby; Evelina Shikova; Lorenzo Lorusso; Enrica Capelli; Slobodan Sekulic; Carmen Scheibenbogen; Nuno Sepúlveda; Modra Murovska; Eliana Lacerda
Journal:  J Clin Med       Date:  2020-05-21       Impact factor: 4.241

Review 6.  Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Human Herpesviruses Are Back!

Authors:  Maria Eugenia Ariza
Journal:  Biomolecules       Date:  2021-01-29

Review 7.  Epstein-Barr Virus and the Origin of Myalgic Encephalomyelitis or Chronic Fatigue Syndrome.

Authors:  Manuel Ruiz-Pablos; Bruno Paiva; Rosario Montero-Mateo; Nicolas Garcia; Aintzane Zabaleta
Journal:  Front Immunol       Date:  2021-11-15       Impact factor: 7.561

8.  A Natural History of Disease Framework for Improving the Prevention, Management, and Research on Post-viral Fatigue Syndrome and Other Forms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Shennae O'Boyle; Luis Nacul; Flavio E Nacul; Kathleen Mudie; Caroline C Kingdon; Jacqueline M Cliff; Taane G Clark; Hazel M Dockrell; Eliana M Lacerda
Journal:  Front Med (Lausanne)       Date:  2022-01-28

9.  Commentary: Antibodies to Human Herpesviruses in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.

Authors:  Maria Eugenia Ariza
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

Review 10.  Stress-Induced Epstein-Barr Virus Reactivation.

Authors:  Daniel G Sausen; Maimoona S Bhutta; Elisa S Gallo; Harel Dahari; Ronen Borenstein
Journal:  Biomolecules       Date:  2021-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.